NovoPath this week announced the launch of new solutions for oncology diagnostic laboratories.
Its NovoPath 360 SaaS-LIS product now supports all diagnostic techniques for solid tumor and hematopathology from a single platform, reducing overall laboratory complexities, cost, and turnaround times, the firm said.
Techniques include NGS, FISH, flow cytometry, genomic molecular methods, morphology, and cytogenetics, as well as laboratory developed tests.
NovoPath 360 workflow solutions seamlessly integrate into instruments, billing systems, electronic medical records (EMRs), and other third-party systems to provide labs with an efficient way to manage and perform the molecular diagnostic techniques, the company said.
NovoPath 360 LIS solutions make it easier to receive orders, manage workflows, and diagnose hematopathology and solid tumor diseases, the vendor added.